From: Expression and function of myelin expression factor 2 in hepatocellular carcinoma
Factor | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% confidence interval | P-value | Hazard ratio | 95% confidence interval | P-value | |
MYEF2 | 0.636 | 0.439–0.920 | 0.016 | 0.670 | 0.451–0.995 | 0.047 |
Age (years) | 1.190 | 0.840–1.687 | 0.328 | |||
Gender | 1.248 | 0.876–1.777 | 0.219 | |||
Tumor stage | 0.487 | 0.335–0.710 | < 0.001 | 0.326 | 0.041–2.600 | 0.290 |
Tumor grade | 0.898 | 0.628–1.258 | 0.557 | |||
Pathologic T | 0.479 | 0.334–0.685 | < 0.001 | 1.563 | 0.201–12.121 | 0.669 |
Lymph node metastasis | 0.676 | 0.469–0.973 | 0.035 | 1.122 | 0.662–1.903 | 0.669 |
Distant metastasis | 0.613 | 0.426–0.883 | 0.009 | 0.567 | 0.337–0.954 | 0.032 |
AFP | 0.910 | 0.572–1.450 | 0.692 |